13767 Responder characteristics in patients with molluscum contagiosum (MC) treated with VP-102 achieving complete clearance: Pooled results of two phase 3 multicenter, randomized, vehicle-controlled trials for the topical treatment of MC

2020 ◽  
Vol 83 (6) ◽  
pp. AB122
Author(s):  
Lawrence F. Eichenfield ◽  
Steven R. Cohen ◽  
Janice L. Pelletier ◽  
Pieter d’Arnaud ◽  
Melissa Olivadoti ◽  
...  
Keyword(s):  
Topical Treatment ◽  
Molluscum Contagiosum ◽  
Controlled Trials ◽  
Phase 3 ◽  
Two Phase ◽  
Complete Clearance

scholarly journals Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo-controlled trials

2018 ◽  
Vol 93 (7) ◽  
pp. 921-930 ◽  
Author(s):  
James Bussel ◽  
Donald M. Arnold ◽  
Elliot Grossbard ◽  
Jiří Mayer ◽  
Jacek Treliński ◽  
...  
Keyword(s):  
Immune Thrombocytopenia ◽  
Controlled Trials ◽  
Phase 3 ◽  
Two Phase ◽  
Chronic Immune Thrombocytopenia

scholarly journals Specifically Targeting Interleukin-13 with Tralokinumab Improved Sleep in Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Trials in Patients with Atopic Dermatitis

2021 ◽  
Vol 5 (1) ◽  
pp. s9
Author(s):  
Jonathan Silverberg ◽  
Sebastien Barbarot ◽  
Melinda Gooderham ◽  
Jan Simon ◽  
Eric Simpson ◽  
...  
Keyword(s):  
Atopic Dermatitis ◽  
Controlled Trials ◽  
Phase 3 ◽  
Two Phase ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Interleukin 13

Abstract not available.

Sign in / Sign up

Export Citation Format

Share Document